Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.64181879 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.64181879 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.26391053 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26391053 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.91501849 |
6 | indole-containing compound catabolic process (GO:0042436) | 6.30361745 |
7 | indolalkylamine catabolic process (GO:0046218) | 6.30361745 |
8 | tryptophan catabolic process (GO:0006569) | 6.30361745 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.17742246 |
10 | kynurenine metabolic process (GO:0070189) | 6.10072980 |
11 | bile acid biosynthetic process (GO:0006699) | 5.97143529 |
12 | tryptophan metabolic process (GO:0006568) | 5.91887638 |
13 | urea metabolic process (GO:0019627) | 5.83427054 |
14 | urea cycle (GO:0000050) | 5.83427054 |
15 | glyoxylate metabolic process (GO:0046487) | 5.65451890 |
16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.51221193 |
17 | negative regulation of fibrinolysis (GO:0051918) | 5.48262398 |
18 | complement activation, alternative pathway (GO:0006957) | 5.45648303 |
19 | protein carboxylation (GO:0018214) | 5.40887099 |
20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.40887099 |
21 | sulfur amino acid catabolic process (GO:0000098) | 5.38064371 |
22 | nitrogen cycle metabolic process (GO:0071941) | 5.36413035 |
23 | regulation of fibrinolysis (GO:0051917) | 5.35873175 |
24 | regulation of protein activation cascade (GO:2000257) | 5.35433080 |
25 | cysteine metabolic process (GO:0006534) | 5.34903657 |
26 | alpha-linolenic acid metabolic process (GO:0036109) | 5.34632664 |
27 | detection of other organism (GO:0098543) | 5.27101300 |
28 | serine family amino acid catabolic process (GO:0009071) | 5.14559750 |
29 | bile acid metabolic process (GO:0008206) | 5.08476396 |
30 | detection of bacterium (GO:0016045) | 5.06240541 |
31 | regulation of complement activation (GO:0030449) | 5.01898488 |
32 | aromatic amino acid family metabolic process (GO:0009072) | 5.00056393 |
33 | homocysteine metabolic process (GO:0050667) | 4.93384399 |
34 | detection of molecule of bacterial origin (GO:0032490) | 4.93384381 |
35 | detection of external biotic stimulus (GO:0098581) | 4.87679265 |
36 | tyrosine metabolic process (GO:0006570) | 4.83551309 |
37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.79006159 |
38 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.78046272 |
39 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.78046272 |
40 | regulation of cholesterol esterification (GO:0010872) | 4.78017580 |
41 | reverse cholesterol transport (GO:0043691) | 4.77441288 |
42 | regulation of triglyceride catabolic process (GO:0010896) | 4.75895867 |
43 | phospholipid efflux (GO:0033700) | 4.71590484 |
44 | protein-lipid complex remodeling (GO:0034368) | 4.69802712 |
45 | macromolecular complex remodeling (GO:0034367) | 4.69802712 |
46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.69802712 |
47 | * alpha-amino acid catabolic process (GO:1901606) | 4.62634576 |
48 | amino-acid betaine metabolic process (GO:0006577) | 4.60667269 |
49 | acylglycerol homeostasis (GO:0055090) | 4.60131269 |
50 | triglyceride homeostasis (GO:0070328) | 4.60131269 |
51 | indolalkylamine metabolic process (GO:0006586) | 4.47567306 |
52 | negative regulation of cholesterol transport (GO:0032375) | 4.46590098 |
53 | negative regulation of sterol transport (GO:0032372) | 4.46590098 |
54 | lysine metabolic process (GO:0006553) | 4.46408306 |
55 | lysine catabolic process (GO:0006554) | 4.46408306 |
56 | epoxygenase P450 pathway (GO:0019373) | 4.43719109 |
57 | exogenous drug catabolic process (GO:0042738) | 4.42425065 |
58 | coenzyme catabolic process (GO:0009109) | 4.42351152 |
59 | amine catabolic process (GO:0009310) | 4.41969773 |
60 | cellular biogenic amine catabolic process (GO:0042402) | 4.41969773 |
61 | bile acid and bile salt transport (GO:0015721) | 4.41891209 |
62 | omega-hydroxylase P450 pathway (GO:0097267) | 4.40683528 |
63 | glycine metabolic process (GO:0006544) | 4.34684515 |
64 | plasma lipoprotein particle clearance (GO:0034381) | 4.33846666 |
65 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.28358348 |
66 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.27153242 |
67 | modulation by symbiont of host immune response (GO:0052553) | 4.27153242 |
68 | positive regulation by symbiont of host defense response (GO:0052509) | 4.27153242 |
69 | modulation by symbiont of host defense response (GO:0052031) | 4.27153242 |
70 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.27153242 |
71 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.27153242 |
72 | cellular ketone body metabolic process (GO:0046950) | 4.27035231 |
73 | cellular glucuronidation (GO:0052695) | 4.26332721 |
74 | detection of biotic stimulus (GO:0009595) | 4.25609019 |
75 | * cellular amino acid catabolic process (GO:0009063) | 4.24077961 |
76 | negative regulation of protein activation cascade (GO:2000258) | 4.20573281 |
77 | cholesterol efflux (GO:0033344) | 4.19660448 |
78 | regulation of humoral immune response (GO:0002920) | 4.19277131 |
79 | benzene-containing compound metabolic process (GO:0042537) | 4.13319898 |
80 | serine family amino acid metabolic process (GO:0009069) | 4.12906257 |
81 | fibrinolysis (GO:0042730) | 4.12293235 |
82 | arginine metabolic process (GO:0006525) | 4.08928619 |
83 | cellular modified amino acid catabolic process (GO:0042219) | 4.08120982 |
84 | ethanol oxidation (GO:0006069) | 4.07929702 |
85 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.06098350 |
86 | negative regulation of cell killing (GO:0031342) | 4.06098350 |
87 | * imidazole-containing compound metabolic process (GO:0052803) | 4.05642538 |
88 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.03841608 |
89 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01061182 |
90 | aldehyde catabolic process (GO:0046185) | 3.98386608 |
91 | * glutamate metabolic process (GO:0006536) | 3.98020682 |
92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95620028 |
93 | serine family amino acid biosynthetic process (GO:0009070) | 3.94804022 |
94 | plasma lipoprotein particle assembly (GO:0034377) | 3.92279955 |
95 | blood coagulation, intrinsic pathway (GO:0007597) | 3.84160601 |
96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.82754832 |
97 | complement activation (GO:0006956) | 3.81740782 |
98 | drug catabolic process (GO:0042737) | 3.81373956 |
99 | negative regulation of lipase activity (GO:0060192) | 3.81052366 |
100 | complement activation, classical pathway (GO:0006958) | 3.80878991 |
101 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80790138 |
102 | cofactor catabolic process (GO:0051187) | 3.80660775 |
103 | glucuronate metabolic process (GO:0019585) | 3.80326192 |
104 | uronic acid metabolic process (GO:0006063) | 3.80326192 |
105 | protein activation cascade (GO:0072376) | 3.78478746 |
106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73639800 |
107 | macrophage activation involved in immune response (GO:0002281) | 3.73316430 |
108 | cholesterol homeostasis (GO:0042632) | 3.71188655 |
109 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.71052509 |
110 | acute-phase response (GO:0006953) | 3.69949734 |
111 | * organic acid catabolic process (GO:0016054) | 3.69375006 |
112 | * carboxylic acid catabolic process (GO:0046395) | 3.69375006 |
113 | ketone body metabolic process (GO:1902224) | 3.69121346 |
114 | neutrophil activation involved in immune response (GO:0002283) | 3.68075830 |
115 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65911172 |
116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65911172 |
117 | acetyl-CoA metabolic process (GO:0006084) | 3.65170781 |
118 | sterol homeostasis (GO:0055092) | 3.64442947 |
119 | regulation of cholesterol homeostasis (GO:2000188) | 3.64251948 |
120 | phospholipid homeostasis (GO:0055091) | 3.64249798 |
121 | cytolysis (GO:0019835) | 3.64079740 |
122 | positive regulation of lipid catabolic process (GO:0050996) | 3.62593453 |
123 | NAD biosynthetic process (GO:0009435) | 3.62472250 |
124 | opsonization (GO:0008228) | 3.56929735 |
125 | plasma lipoprotein particle organization (GO:0071827) | 3.56794920 |
126 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.56220783 |
127 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.56220783 |
128 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.55763954 |
129 | cellular extravasation (GO:0045123) | 3.55710936 |
130 | keratinization (GO:0031424) | 3.51552535 |
131 | negative regulation of complement activation (GO:0045916) | 3.48476488 |
132 | positive regulation of blood coagulation (GO:0030194) | 3.43307379 |
133 | positive regulation of hemostasis (GO:1900048) | 3.43307379 |
134 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.42797034 |
135 | establishment of skin barrier (GO:0061436) | 3.41950902 |
136 | response to peptidoglycan (GO:0032494) | 3.38974536 |
137 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.37015941 |
138 | negative regulation of B cell mediated immunity (GO:0002713) | 3.35011025 |
139 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.35011025 |
140 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.34822635 |
141 | neutrophil mediated immunity (GO:0002446) | 3.26928258 |
142 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.26630678 |
143 | negative regulation of humoral immune response (GO:0002921) | 3.23831064 |
144 | positive regulation of coagulation (GO:0050820) | 3.18923400 |
145 | negative regulation of hemostasis (GO:1900047) | 3.11925634 |
146 | negative regulation of blood coagulation (GO:0030195) | 3.11925634 |
147 | microglial cell activation (GO:0001774) | 3.07275894 |
148 | regulation of gamma-delta T cell activation (GO:0046643) | 3.04961258 |
149 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04213664 |
150 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.03153303 |
151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01893956 |
152 | neutrophil activation (GO:0042119) | 3.01602173 |
153 | regulation of acute inflammatory response (GO:0002673) | 2.97171565 |
154 | response to interleukin-15 (GO:0070672) | 2.92773490 |
155 | macrophage activation (GO:0042116) | 2.92230255 |
156 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.90838550 |
157 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.89549800 |
158 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.88997990 |
159 | acute inflammatory response (GO:0002526) | 2.88820945 |
160 | regulation of apoptotic cell clearance (GO:2000425) | 2.88781016 |
161 | regulation of water loss via skin (GO:0033561) | 2.86910381 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.15082067 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.98226648 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.98177838 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.36219982 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.26985512 |
6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.83094824 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.56757909 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97918629 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77910400 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.25937998 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.14776868 |
12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.96759012 |
13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86310214 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.71043076 |
15 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64195530 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.63457958 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44985051 |
18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43117713 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.26458210 |
20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23977002 |
21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.20172852 |
22 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5239896 |
23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99745622 |
24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99237673 |
25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84705396 |
26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81402887 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.81302240 |
28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.80457058 |
29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78969185 |
30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76001168 |
31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.75664570 |
32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71242809 |
33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70241256 |
34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69346185 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68417124 |
36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.66825268 |
37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.66597285 |
38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58531295 |
39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56706503 |
40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53956221 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 1.52198572 |
42 | MYB_26560356_Chip-Seq_TH2_Human | 1.50029435 |
43 | MAF_26560356_Chip-Seq_TH1_Human | 1.43736205 |
44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39714743 |
45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39056434 |
46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39037643 |
47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37196123 |
48 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31376897 |
49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30640630 |
50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28580851 |
51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28547008 |
52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27645557 |
53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25914567 |
54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25348708 |
55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24065262 |
56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22722395 |
57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21752631 |
58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21387794 |
59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18588573 |
60 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17609729 |
61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17129511 |
62 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.14715436 |
63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14654544 |
64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14620022 |
65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12891771 |
66 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.12036262 |
67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08424720 |
68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08113078 |
69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07285084 |
70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06140313 |
71 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05381746 |
72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01166523 |
73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99031713 |
74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97748503 |
75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95627870 |
76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94832504 |
77 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94682258 |
78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90883726 |
79 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.90698136 |
80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89686004 |
81 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89339971 |
82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89214425 |
83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88890977 |
84 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88644971 |
85 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88641878 |
86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86988072 |
87 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86356768 |
88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85736479 |
89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85735740 |
90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85647109 |
91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85478573 |
92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85264156 |
93 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84060516 |
94 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83983365 |
95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83815158 |
96 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83412055 |
97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83278887 |
98 | MAF_26560356_Chip-Seq_TH2_Human | 0.82228990 |
99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82050857 |
100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81809194 |
101 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80451552 |
102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.78560113 |
103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76533810 |
104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73326778 |
105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73326778 |
106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72946185 |
107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72220501 |
108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71653856 |
109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68088535 |
110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67698205 |
111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66959902 |
112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66932893 |
113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66014916 |
114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65801865 |
115 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.65217942 |
116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65128184 |
117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63230695 |
118 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.61495619 |
119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61207657 |
120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60395356 |
121 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.59492452 |
122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.59094961 |
123 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58746488 |
124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57438202 |
125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57302175 |
126 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57028691 |
127 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54853197 |
128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54688429 |
129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.54314505 |
130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54039723 |
131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53236807 |
132 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51952716 |
133 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51756399 |
134 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50449100 |
135 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49934680 |
136 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49849985 |
137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.49534362 |
138 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.48189657 |
139 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.48132689 |
140 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.46831718 |
141 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45282325 |
142 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.45190651 |
143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.45088815 |
144 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44330970 |
145 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.43530382 |
146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.43417750 |
147 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43321820 |
148 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42796677 |
149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42049489 |
150 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42029637 |
151 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41799295 |
152 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.41547292 |
153 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41002624 |
154 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.40894399 |
155 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40403715 |
156 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.39498241 |
157 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39319218 |
158 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39132831 |
159 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38684722 |
160 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.37942052 |
161 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37856552 |
162 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.37714550 |
163 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37438376 |
164 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.36799010 |
165 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.36798710 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.05778729 |
2 | MP0005360_urolithiasis | 7.49370710 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.36736168 |
4 | MP0005365_abnormal_bile_salt | 6.04829097 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04559941 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.13868524 |
7 | MP0003252_abnormal_bile_duct | 3.84870567 |
8 | MP0010329_abnormal_lipoprotein_level | 3.50272990 |
9 | MP0009840_abnormal_foam_cell | 3.16689983 |
10 | MP0005083_abnormal_biliary_tract | 2.99681913 |
11 | MP0003195_calcinosis | 2.90722368 |
12 | MP0005332_abnormal_amino_acid | 2.72046518 |
13 | MP0001666_abnormal_nutrient_absorption | 2.52351631 |
14 | MP0002419_abnormal_innate_immunity | 2.44606122 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.44043545 |
16 | MP0003303_peritoneal_inflammation | 2.31915697 |
17 | MP0001835_abnormal_antigen_presentation | 2.19606593 |
18 | MP0004019_abnormal_vitamin_homeostasis | 2.16374679 |
19 | MP0009785_altered_susceptibility_to | 2.13561677 |
20 | MP0000609_abnormal_liver_physiology | 2.11212518 |
21 | MP0005025_abnormal_response_to | 2.11182674 |
22 | MP0002118_abnormal_lipid_homeostasis | 2.07958496 |
23 | MP0005451_abnormal_body_composition | 1.96245534 |
24 | MP0002138_abnormal_hepatobiliary_system | 1.94605731 |
25 | MP0000685_abnormal_immune_system | 1.92842780 |
26 | MP0001800_abnormal_humoral_immune | 1.91167192 |
27 | MP0003868_abnormal_feces_composition | 1.83646914 |
28 | MP0005319_abnormal_enzyme/_coenzyme | 1.75559818 |
29 | MP0004883_abnormal_blood_vessel | 1.70728938 |
30 | MP0005387_immune_system_phenotype | 1.68237397 |
31 | MP0001790_abnormal_immune_system | 1.68237397 |
32 | MP0001764_abnormal_homeostasis | 1.64908636 |
33 | MP0005000_abnormal_immune_tolerance | 1.63046458 |
34 | MP0002723_abnormal_immune_serum | 1.61125382 |
35 | MP0001533_abnormal_skeleton_physiology | 1.58072881 |
36 | MP0002254_reproductive_system_inflammat | 1.57197196 |
37 | MP0008260_abnormal_autophagy | 1.53705821 |
38 | MP0009697_abnormal_copulation | 1.51220250 |
39 | MP0005671_abnormal_response_to | 1.50933251 |
40 | MP0002420_abnormal_adaptive_immunity | 1.49963157 |
41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48887641 |
42 | MP0001819_abnormal_immune_cell | 1.48051207 |
43 | MP0001851_eye_inflammation | 1.45328792 |
44 | MP0002452_abnormal_antigen_presenting | 1.44600052 |
45 | MP0000465_gastrointestinal_hemorrhage | 1.42537159 |
46 | MP0005164_abnormal_response_to | 1.42198119 |
47 | MP0003011_delayed_dark_adaptation | 1.42039791 |
48 | MP0003828_pulmonary_edema | 1.41995685 |
49 | MP0003300_gastrointestinal_ulcer | 1.38894526 |
50 | MP0003172_abnormal_lysosome_physiology | 1.33860199 |
51 | MP0002405_respiratory_system_inflammati | 1.30462441 |
52 | MP0003763_abnormal_thymus_physiology | 1.29587016 |
53 | MP0005647_abnormal_sex_gland | 1.22987533 |
54 | MP0003705_abnormal_hypodermis_morpholog | 1.21105075 |
55 | MP0003186_abnormal_redox_activity | 1.20511274 |
56 | MP0002148_abnormal_hypersensitivity_rea | 1.20139890 |
57 | MP0010155_abnormal_intestine_physiology | 1.18996253 |
58 | MP0009643_abnormal_urine_homeostasis | 1.17130496 |
59 | MP0000858_altered_metastatic_potential | 1.16886430 |
60 | MP0002796_impaired_skin_barrier | 1.16806105 |
61 | MP0003656_abnormal_erythrocyte_physiolo | 1.13168803 |
62 | MP0009764_decreased_sensitivity_to | 1.10003923 |
63 | MP0000598_abnormal_liver_morphology | 1.09662104 |
64 | MP0002277_abnormal_respiratory_mucosa | 1.09153038 |
65 | MP0000716_abnormal_immune_system | 1.07819688 |
66 | MP0000604_amyloidosis | 1.06847285 |
67 | MP0002396_abnormal_hematopoietic_system | 1.06237062 |
68 | MP0001545_abnormal_hematopoietic_system | 1.05578085 |
69 | MP0005397_hematopoietic_system_phenotyp | 1.05578085 |
70 | MP0002398_abnormal_bone_marrow | 1.05560182 |
71 | MP0002166_altered_tumor_susceptibility | 1.04331325 |
72 | MP0003878_abnormal_ear_physiology | 1.01425267 |
73 | MP0005377_hearing/vestibular/ear_phenot | 1.01425267 |
74 | MP0009763_increased_sensitivity_to | 1.01393252 |
75 | MP0000689_abnormal_spleen_morphology | 1.00527228 |
76 | MP0001915_intracranial_hemorrhage | 0.98870090 |
77 | MP0009333_abnormal_splenocyte_physiolog | 0.97617591 |
78 | MP0002998_abnormal_bone_remodeling | 0.96063717 |
79 | MP0002722_abnormal_immune_system | 0.95152790 |
80 | MP0003183_abnormal_peptide_metabolism | 0.94080160 |
81 | MP0002876_abnormal_thyroid_physiology | 0.92869848 |
82 | MP0000569_abnormal_digit_pigmentation | 0.90442726 |
83 | MP0004381_abnormal_hair_follicle | 0.88899460 |
84 | MP0008469_abnormal_protein_level | 0.88422695 |
85 | MP0005636_abnormal_mineral_homeostasis | 0.85754283 |
86 | MP0010368_abnormal_lymphatic_system | 0.84169411 |
87 | MP0009642_abnormal_blood_homeostasis | 0.83222222 |
88 | MP0005408_hypopigmentation | 0.80632452 |
89 | MP0009765_abnormal_xenobiotic_induced | 0.79753836 |
90 | MP0002429_abnormal_blood_cell | 0.78993635 |
91 | MP0005670_abnormal_white_adipose | 0.78547983 |
92 | MP0003866_abnormal_defecation | 0.77893238 |
93 | MP0002009_preneoplasia | 0.77077307 |
94 | MP0002971_abnormal_brown_adipose | 0.75836309 |
95 | MP0005058_abnormal_lysosome_morphology | 0.74980377 |
96 | MP0005376_homeostasis/metabolism_phenot | 0.74938212 |
97 | MP0000249_abnormal_blood_vessel | 0.71595133 |
98 | MP0002078_abnormal_glucose_homeostasis | 0.70824140 |
99 | MP0000015_abnormal_ear_pigmentation | 0.69971226 |
100 | MP0005334_abnormal_fat_pad | 0.69173752 |
101 | MP0006036_abnormal_mitochondrial_physio | 0.67156747 |
102 | MP0005084_abnormal_gallbladder_morpholo | 0.67061521 |
103 | MP0003690_abnormal_glial_cell | 0.66502611 |
104 | MP0005409_darkened_coat_color | 0.65794916 |
105 | MP0005220_abnormal_exocrine_pancreas | 0.65091219 |
106 | MP0004782_abnormal_surfactant_physiolog | 0.64380789 |
107 | MP0005535_abnormal_body_temperature | 0.63616039 |
108 | MP0000579_abnormal_nail_morphology | 0.63297303 |
109 | MP0009053_abnormal_anal_canal | 0.62525125 |
110 | MP0001661_extended_life_span | 0.62218009 |
111 | MP0003329_amyloid_beta_deposits | 0.61190831 |
112 | MP0004130_abnormal_muscle_cell | 0.61131650 |
113 | MP0002060_abnormal_skin_morphology | 0.61101204 |
114 | MP0010234_abnormal_vibrissa_follicle | 0.60137676 |
115 | MP0005266_abnormal_metabolism | 0.57059705 |
116 | MP0005448_abnormal_energy_balance | 0.55510137 |
117 | MP0005464_abnormal_platelet_physiology | 0.54841759 |
118 | MP0003436_decreased_susceptibility_to | 0.54160914 |
119 | MP0000639_abnormal_adrenal_gland | 0.54126534 |
120 | MP0003724_increased_susceptibility_to | 0.52445991 |
121 | MP0001756_abnormal_urination | 0.51757285 |
122 | MP0003638_abnormal_response/metabolism_ | 0.51466375 |
123 | MP0005501_abnormal_skin_physiology | 0.50840909 |
124 | MP0003453_abnormal_keratinocyte_physiol | 0.47433802 |
125 | MP0005395_other_phenotype | 0.46484045 |
126 | MP0004947_skin_inflammation | 0.46079017 |
127 | MP0003718_maternal_effect | 0.46035199 |
128 | MP0008874_decreased_physiological_sensi | 0.45407767 |
129 | MP0006035_abnormal_mitochondrial_morpho | 0.44923420 |
130 | MP0006082_CNS_inflammation | 0.44749718 |
131 | MP0001243_abnormal_dermal_layer | 0.43826626 |
132 | MP0002136_abnormal_kidney_physiology | 0.43473283 |
133 | MP0000427_abnormal_hair_cycle | 0.43230280 |
134 | MP0002822_catalepsy | 0.42544936 |
135 | MP0005248_abnormal_Harderian_gland | 0.41202039 |
136 | MP0008873_increased_physiological_sensi | 0.41006073 |
137 | MP0003075_altered_response_to | 0.40962979 |
138 | MP0002928_abnormal_bile_duct | 0.39542825 |
139 | MP0005666_abnormal_adipose_tissue | 0.39123227 |
140 | MP0001216_abnormal_epidermal_layer | 0.38840792 |
141 | MP0005275_abnormal_skin_tensile | 0.37530656 |
142 | MP0005166_decreased_susceptibility_to | 0.36218271 |
143 | MP0003953_abnormal_hormone_level | 0.35853851 |
144 | MP0000647_abnormal_sebaceous_gland | 0.33800069 |
145 | MP0009384_cardiac_valve_regurgitation | 0.33480425 |
146 | MP0009115_abnormal_fat_cell | 0.33471326 |
147 | MP0009672_abnormal_birth_weight | 0.33034304 |
148 | MP0001853_heart_inflammation | 0.32562115 |
149 | MP0009931_abnormal_skin_appearance | 0.31222258 |
150 | MP0002132_abnormal_respiratory_system | 0.30969174 |
151 | MP0001845_abnormal_inflammatory_respons | 0.30882982 |
152 | MP0008872_abnormal_physiological_respon | 0.30105889 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.42400096 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.41340801 |
3 | Deep venous thrombosis (HP:0002625) | 7.37339863 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.80038808 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.68386312 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.35410230 |
7 | Xanthomatosis (HP:0000991) | 6.28398012 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.55653912 |
9 | Complement deficiency (HP:0004431) | 5.52053527 |
10 | Eczematoid dermatitis (HP:0000976) | 5.50983831 |
11 | Joint hemorrhage (HP:0005261) | 4.92926792 |
12 | Increased IgE level (HP:0003212) | 4.82854275 |
13 | Hypolipoproteinemia (HP:0010981) | 4.73427626 |
14 | Epidermoid cyst (HP:0200040) | 4.61619724 |
15 | Hyperammonemia (HP:0001987) | 4.53087393 |
16 | Myositis (HP:0100614) | 4.39918218 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.39321722 |
18 | Orchitis (HP:0100796) | 4.38713383 |
19 | Hyperglycinemia (HP:0002154) | 4.35705548 |
20 | Abnormality of methionine metabolism (HP:0010901) | 4.35067347 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.34999094 |
22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.29471618 |
23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.28283462 |
24 | Optic neuritis (HP:0100653) | 4.22349925 |
25 | Retrobulbar optic neuritis (HP:0100654) | 4.22349925 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15770736 |
27 | Fat malabsorption (HP:0002630) | 4.15651414 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 4.12477593 |
29 | Abnormality of complement system (HP:0005339) | 4.11601851 |
30 | Ketosis (HP:0001946) | 4.08939111 |
31 | Gangrene (HP:0100758) | 3.97558075 |
32 | Recurrent bacterial skin infections (HP:0005406) | 3.95337128 |
33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91291256 |
34 | Hyperglycinuria (HP:0003108) | 3.90214970 |
35 | Abnormality of glycine metabolism (HP:0010895) | 3.86664137 |
36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86664137 |
37 | Recurrent abscess formation (HP:0002722) | 3.85775190 |
38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.83424232 |
39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.68208460 |
40 | Hypoglycemic coma (HP:0001325) | 3.64077927 |
41 | Hypercholesterolemia (HP:0003124) | 3.62257930 |
42 | Keratoconjunctivitis sicca (HP:0001097) | 3.51092108 |
43 | Gastrointestinal infarctions (HP:0005244) | 3.36568674 |
44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27080473 |
45 | Hyperbilirubinemia (HP:0002904) | 3.26166709 |
46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23481097 |
47 | Keratoconjunctivitis (HP:0001096) | 3.19318055 |
48 | Steatorrhea (HP:0002570) | 3.16862764 |
49 | Recurrent skin infections (HP:0001581) | 3.11223965 |
50 | Myocardial infarction (HP:0001658) | 3.08499262 |
51 | Delayed CNS myelination (HP:0002188) | 3.07262026 |
52 | Systemic lupus erythematosus (HP:0002725) | 3.06077912 |
53 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04208564 |
54 | Epistaxis (HP:0000421) | 3.04165491 |
55 | Abnormality of serum amino acid levels (HP:0003112) | 3.04085435 |
56 | Abnormality of macrophages (HP:0004311) | 2.99247176 |
57 | Abnormality of secondary sexual hair (HP:0009888) | 2.98458684 |
58 | Abnormality of the axillary hair (HP:0100134) | 2.98458684 |
59 | Spontaneous hematomas (HP:0007420) | 2.93824584 |
60 | Hypochromic microcytic anemia (HP:0004840) | 2.90159967 |
61 | Spontaneous abortion (HP:0005268) | 2.89284934 |
62 | Hepatocellular carcinoma (HP:0001402) | 2.88021713 |
63 | Meningitis (HP:0001287) | 2.83607728 |
64 | Ketoacidosis (HP:0001993) | 2.82087086 |
65 | Peritonitis (HP:0002586) | 2.80792366 |
66 | Skin nodule (HP:0200036) | 2.76941345 |
67 | Stomatitis (HP:0010280) | 2.73560145 |
68 | Gingivitis (HP:0000230) | 2.72639209 |
69 | Purpura (HP:0000979) | 2.72152697 |
70 | Urticaria (HP:0001025) | 2.71098225 |
71 | Hypochromic anemia (HP:0001931) | 2.70054922 |
72 | Metabolic acidosis (HP:0001942) | 2.68256877 |
73 | Vascular calcification (HP:0004934) | 2.66799126 |
74 | Prolonged bleeding time (HP:0003010) | 2.65664472 |
75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.64222484 |
76 | Abnormality of nail color (HP:0100643) | 2.61126975 |
77 | Glomerulonephritis (HP:0000099) | 2.61061603 |
78 | Abnormality of purine metabolism (HP:0004352) | 2.60667218 |
79 | Anorexia (HP:0002039) | 2.56546792 |
80 | Arterial thrombosis (HP:0004420) | 2.55485815 |
81 | Lethargy (HP:0001254) | 2.52374791 |
82 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50777148 |
83 | Mitral stenosis (HP:0001718) | 2.49597858 |
84 | Chronic obstructive pulmonary disease (HP:0006510) | 2.49120843 |
85 | Obstructive lung disease (HP:0006536) | 2.49120843 |
86 | Acanthocytosis (HP:0001927) | 2.48877383 |
87 | Dicarboxylic aciduria (HP:0003215) | 2.48024485 |
88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48024485 |
89 | Abnormal gallbladder morphology (HP:0012437) | 2.44459860 |
90 | Amyloidosis (HP:0011034) | 2.38596280 |
91 | Neonatal onset (HP:0003623) | 2.38129951 |
92 | Cerebral edema (HP:0002181) | 2.37387394 |
93 | Cholelithiasis (HP:0001081) | 2.36597530 |
94 | Cardiovascular calcification (HP:0011915) | 2.36318474 |
95 | Vasculitis (HP:0002633) | 2.35449925 |
96 | Encephalitis (HP:0002383) | 2.34933329 |
97 | Joint swelling (HP:0001386) | 2.34107174 |
98 | Spastic diplegia (HP:0001264) | 2.33289401 |
99 | Irritability (HP:0000737) | 2.31994447 |
100 | Hypoglycemic seizures (HP:0002173) | 2.30989822 |
101 | Erythroderma (HP:0001019) | 2.30634967 |
102 | Recurrent fungal infections (HP:0002841) | 2.29025257 |
103 | Palmoplantar hyperkeratosis (HP:0000972) | 2.27820610 |
104 | Mediastinal lymphadenopathy (HP:0100721) | 2.27458918 |
105 | Malnutrition (HP:0004395) | 2.27167710 |
106 | Gout (HP:0001997) | 2.25116178 |
107 | Gingival bleeding (HP:0000225) | 2.24365852 |
108 | Cholecystitis (HP:0001082) | 2.23387519 |
109 | Abnormal gallbladder physiology (HP:0012438) | 2.23387519 |
110 | Menorrhagia (HP:0000132) | 2.20802373 |
111 | Hemoptysis (HP:0002105) | 2.20378327 |
112 | Esophageal varix (HP:0002040) | 2.17390403 |
113 | Osteomalacia (HP:0002749) | 2.17364123 |
114 | Pustule (HP:0200039) | 2.15596746 |
115 | Palmar hyperkeratosis (HP:0010765) | 2.14188986 |
116 | Pancreatitis (HP:0001733) | 2.13206317 |
117 | Brushfield spots (HP:0001088) | 2.11136994 |
118 | Increased serum ferritin (HP:0003281) | 2.10059874 |
119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08708713 |
120 | Erythema (HP:0010783) | 2.08129333 |
121 | Enlarged kidneys (HP:0000105) | 2.05647090 |
122 | Thrombophlebitis (HP:0004418) | 2.04266419 |
123 | Thick nail (HP:0001805) | 2.03122907 |
124 | Episodic fever (HP:0001954) | 2.02690337 |
125 | Pulmonary infiltrates (HP:0002113) | 2.02622453 |
126 | Opisthotonus (HP:0002179) | 2.02137701 |
127 | Sensorimotor neuropathy (HP:0007141) | 2.01968019 |
128 | Hemorrhage of the eye (HP:0011885) | 2.01290193 |
129 | Rickets (HP:0002748) | 2.00921579 |
130 | Periodontitis (HP:0000704) | 2.00610322 |
131 | Abnormality of the gallbladder (HP:0005264) | 2.00024832 |
132 | Vomiting (HP:0002013) | 1.99743470 |
133 | Abnormal platelet volume (HP:0011876) | 1.99161742 |
134 | Hypophosphatemic rickets (HP:0004912) | 1.99148863 |
135 | Abnormality of proline metabolism (HP:0010907) | 1.98910005 |
136 | Hydroxyprolinuria (HP:0003080) | 1.98910005 |
137 | Late onset (HP:0003584) | 1.98275880 |
138 | Hypotrichosis (HP:0001006) | 1.97015805 |
139 | Generalized aminoaciduria (HP:0002909) | 1.94084825 |
140 | Poikilocytosis (HP:0004447) | 1.93215108 |
141 | Renal cortical cysts (HP:0000803) | 1.92770195 |
142 | Pruritus (HP:0000989) | 1.88628185 |
143 | Fair hair (HP:0002286) | 1.88526688 |
144 | Recurrent cutaneous fungal infections (HP:0011370) | 1.87203075 |
145 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.87203075 |
146 | Chest pain (HP:0100749) | 1.87013306 |
147 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86521963 |
148 | Nephritis (HP:0000123) | 1.85357370 |
149 | Abnormality of iron homeostasis (HP:0011031) | 1.84286313 |
150 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83190049 |
151 | Polycythemia (HP:0001901) | 1.82891833 |
152 | Hypergammaglobulinemia (HP:0010702) | 1.82786337 |
153 | Alkalosis (HP:0001948) | 1.82142178 |
154 | Abnormality of the peritoneum (HP:0002585) | 1.81806376 |
155 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81178345 |
156 | Parakeratosis (HP:0001036) | 1.81002218 |
157 | Dry hair (HP:0011359) | 1.77514318 |
158 | Premature loss of primary teeth (HP:0006323) | 1.77162098 |
159 | Abnormality of the pleura (HP:0002103) | 1.77072500 |
160 | Elevated hepatic transaminases (HP:0002910) | 1.76786695 |
161 | Acne (HP:0001061) | 1.76396126 |
162 | Abnormal cartilage morphology (HP:0002763) | 1.76367928 |
163 | Status epilepticus (HP:0002133) | 1.72384369 |
164 | Abnormality of vitamin metabolism (HP:0100508) | 1.71506191 |
165 | Pulmonary embolism (HP:0002204) | 1.71477346 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.63140841 |
2 | FGFR4 | 4.62838580 |
3 | SIK1 | 4.49149856 |
4 | ERN1 | 4.20573583 |
5 | RIPK4 | 3.95407079 |
6 | INSRR | 3.12919557 |
7 | TAOK3 | 3.06287513 |
8 | ERBB4 | 2.94057528 |
9 | IRAK4 | 2.92033002 |
10 | MST1R | 2.84524805 |
11 | MAP4K1 | 2.41402791 |
12 | STK24 | 2.37358234 |
13 | MAP2K4 | 2.26139201 |
14 | FES | 2.03843218 |
15 | PIK3CG | 1.97774226 |
16 | TNK2 | 1.88202241 |
17 | ZAP70 | 1.87103151 |
18 | TYK2 | 1.83576880 |
19 | MAPK11 | 1.78376786 |
20 | LATS1 | 1.68537331 |
21 | PKN2 | 1.60738114 |
22 | PRPF4B | 1.57987385 |
23 | MAP3K14 | 1.57860188 |
24 | KIT | 1.57221235 |
25 | FLT3 | 1.55413329 |
26 | DAPK2 | 1.48094603 |
27 | PTK6 | 1.47645929 |
28 | HCK | 1.46249175 |
29 | BTK | 1.44161470 |
30 | FGFR2 | 1.43741422 |
31 | KSR2 | 1.43740085 |
32 | JAK3 | 1.39297166 |
33 | ABL2 | 1.38496363 |
34 | SYK | 1.37532244 |
35 | FGR | 1.34299515 |
36 | NEK9 | 1.32500225 |
37 | MAP3K7 | 1.31973044 |
38 | YES1 | 1.28441413 |
39 | TXK | 1.25977917 |
40 | TAOK1 | 1.25524333 |
41 | TRIB3 | 1.24219094 |
42 | JAK2 | 1.22141748 |
43 | PINK1 | 1.21073900 |
44 | FRK | 1.20170944 |
45 | TBK1 | 1.18338714 |
46 | PRKAA2 | 1.17616277 |
47 | MAP3K3 | 1.09941543 |
48 | LYN | 1.08940205 |
49 | KDR | 1.08825825 |
50 | MAPK15 | 1.08414754 |
51 | NLK | 1.06608926 |
52 | EPHA3 | 1.06260117 |
53 | EPHB1 | 1.05377047 |
54 | JAK1 | 1.03730544 |
55 | MET | 1.02655875 |
56 | ERBB2 | 1.00047582 |
57 | MAP2K3 | 0.96632591 |
58 | MAPK4 | 0.96382985 |
59 | IRAK3 | 0.96064153 |
60 | PDK1 | 0.93195379 |
61 | GRK6 | 0.92749379 |
62 | DYRK1B | 0.91631928 |
63 | MARK2 | 0.91571112 |
64 | LCK | 0.89292250 |
65 | PRKCZ | 0.87892942 |
66 | SIK3 | 0.84833985 |
67 | TEC | 0.82708967 |
68 | MAPK12 | 0.82668650 |
69 | MARK3 | 0.81272491 |
70 | STK38L | 0.81051128 |
71 | CSK | 0.79960454 |
72 | CDK6 | 0.79018697 |
73 | LRRK2 | 0.75485121 |
74 | GRK1 | 0.75435469 |
75 | BLK | 0.74952732 |
76 | MAP3K11 | 0.74072642 |
77 | PRKACG | 0.73146027 |
78 | IKBKE | 0.73130935 |
79 | STK10 | 0.71777909 |
80 | TIE1 | 0.71712465 |
81 | MAP2K6 | 0.71598203 |
82 | MAP3K10 | 0.71384917 |
83 | TGFBR2 | 0.71284383 |
84 | CAMK1D | 0.70340239 |
85 | MATK | 0.69055865 |
86 | RAF1 | 0.67729575 |
87 | CAMK2G | 0.67706203 |
88 | GSK3A | 0.67121284 |
89 | PKN1 | 0.66801908 |
90 | FGFR3 | 0.66374508 |
91 | WNK1 | 0.66296488 |
92 | MAPK7 | 0.65049459 |
93 | BMPR2 | 0.62146477 |
94 | STK11 | 0.60996795 |
95 | CDK12 | 0.60230952 |
96 | PRKCQ | 0.55737888 |
97 | PRKAA1 | 0.54317843 |
98 | SGK3 | 0.53216987 |
99 | CAMKK2 | 0.53068334 |
100 | PBK | 0.52475918 |
101 | TAOK2 | 0.51621347 |
102 | PTK2 | 0.50676461 |
103 | CSF1R | 0.49260128 |
104 | FYN | 0.48789581 |
105 | IGF1R | 0.48507599 |
106 | MAP3K13 | 0.46905701 |
107 | MAP3K6 | 0.44859070 |
108 | IRAK1 | 0.44727253 |
109 | RIPK1 | 0.43777375 |
110 | ICK | 0.43662148 |
111 | EPHA4 | 0.42904509 |
112 | HIPK2 | 0.41530720 |
113 | CSNK1G1 | 0.40231730 |
114 | PRKD2 | 0.40161029 |
115 | SGK2 | 0.40075786 |
116 | PDPK1 | 0.39843745 |
117 | SIK2 | 0.38747428 |
118 | MOS | 0.38535800 |
119 | MAPKAPK2 | 0.38272824 |
120 | MAP2K1 | 0.37875792 |
121 | STK38 | 0.37069939 |
122 | EGFR | 0.35678699 |
123 | MAP3K5 | 0.35470771 |
124 | KSR1 | 0.35109821 |
125 | ITK | 0.34783686 |
126 | TRPM7 | 0.34421580 |
127 | PRKCG | 0.34216321 |
128 | GRK7 | 0.34173438 |
129 | IRAK2 | 0.33898347 |
130 | MAP3K1 | 0.30710468 |
131 | FER | 0.29753204 |
132 | BMX | 0.29590963 |
133 | IKBKB | 0.29502149 |
134 | FGFR1 | 0.28562567 |
135 | PRKCA | 0.28289417 |
136 | CAMK4 | 0.27825672 |
137 | ABL1 | 0.27471350 |
138 | CDK4 | 0.27370291 |
139 | MAPKAPK3 | 0.27022922 |
140 | MAP3K2 | 0.26229278 |
141 | CHUK | 0.24797691 |
142 | EPHB2 | 0.24387613 |
143 | RET | 0.24143989 |
144 | SGK223 | 0.23589025 |
145 | SGK494 | 0.23589025 |
146 | MAP2K2 | 0.22309897 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56083400 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.58934259 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38156356 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31227386 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.13278960 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83003656 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70353759 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59209532 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56156593 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54434802 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41347243 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33510877 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26712674 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20102773 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.06922095 |
16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06669677 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00370596 |
18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98746052 |
19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.98528186 |
20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93367351 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85181480 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84556045 |
23 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.83671352 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82578653 |
25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.78849241 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75547973 |
27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73169482 |
28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73129803 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73012456 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72380835 |
31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68755970 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.66244271 |
33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65282294 |
34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54965143 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52502327 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51398017 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.51109069 |
38 | Bile secretion_Homo sapiens_hsa04976 | 1.44329001 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40848427 |
40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38840407 |
41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34703829 |
42 | ABC transporters_Homo sapiens_hsa02010 | 1.29079344 |
43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28092599 |
44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27492499 |
45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26304686 |
46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25281737 |
47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21841005 |
48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21371000 |
49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19985148 |
50 | Tuberculosis_Homo sapiens_hsa05152 | 1.18555348 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15246699 |
52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14849099 |
53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14415749 |
54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14299116 |
55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14261944 |
56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11357309 |
57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03463778 |
58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02585734 |
59 | Malaria_Homo sapiens_hsa05144 | 1.02162708 |
60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.00389121 |
61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98191909 |
62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95576424 |
63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95316422 |
64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94270142 |
65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92502452 |
66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89503873 |
67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89230811 |
68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86871918 |
69 | Platelet activation_Homo sapiens_hsa04611 | 0.85759173 |
70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85668949 |
71 | Measles_Homo sapiens_hsa05162 | 0.78636363 |
72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78098695 |
73 | Legionellosis_Homo sapiens_hsa05134 | 0.77300959 |
74 | Lysine degradation_Homo sapiens_hsa00310 | 0.76617019 |
75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76247594 |
76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76094932 |
77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72791016 |
78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72374960 |
79 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72000051 |
80 | Influenza A_Homo sapiens_hsa05164 | 0.71452719 |
81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66758160 |
82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66298172 |
83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65275789 |
84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63613466 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63612615 |
86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62712282 |
87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61978016 |
88 | Phagosome_Homo sapiens_hsa04145 | 0.61383815 |
89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60402995 |
90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58679906 |
91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58097500 |
92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56905267 |
93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56748196 |
94 | Allograft rejection_Homo sapiens_hsa05330 | 0.55844627 |
95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54546701 |
96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53550547 |
97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51688616 |
98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51135232 |
99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49827236 |
100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49418358 |
101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49309242 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48775976 |
103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48276076 |
104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47552634 |
105 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45450478 |
106 | Hepatitis B_Homo sapiens_hsa05161 | 0.40139065 |
107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39623982 |
108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38578744 |
109 | Prion diseases_Homo sapiens_hsa05020 | 0.37459820 |
110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36996121 |
111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33560740 |
112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31666192 |
113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31611921 |
114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30265161 |
115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30171996 |
116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30019507 |
117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29111526 |
118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.28814013 |
119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26792899 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21558706 |
121 | Insulin resistance_Homo sapiens_hsa04931 | 0.20707242 |
122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19583099 |
123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18929275 |
124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18536380 |
125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15067988 |
126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04895775 |
127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01168132 |
128 | Lysosome_Homo sapiens_hsa04142 | -0.2527299 |
129 | Bladder cancer_Homo sapiens_hsa05219 | -0.2503200 |
130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2493725 |
131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2443257 |
132 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2166920 |
133 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2132174 |
134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2087326 |
135 | Amoebiasis_Homo sapiens_hsa05146 | -0.1977488 |
136 | Pertussis_Homo sapiens_hsa05133 | -0.1796189 |
137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1546090 |
138 | Hepatitis C_Homo sapiens_hsa05160 | -0.1467208 |
139 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1425195 |
140 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1343270 |
141 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1147915 |
142 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1128403 |
143 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1062025 |
144 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0905792 |
145 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0902014 |
146 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0619431 |
147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0408348 |
148 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0186865 |